©The Author(s) 2025.
World J Stem Cells. Sep 26, 2025; 17(9): 110663
Published online Sep 26, 2025. doi: 10.4252/wjsc.v17.i9.110663
Published online Sep 26, 2025. doi: 10.4252/wjsc.v17.i9.110663
Table 2 Comparison of clinical efficacy between the control and observation groups, n (%)
| Group | Control group | Observation group | χ2 | P value |
| N | 78 | 78 | ||
| Clinical efficacy | 6.225 | 0.013 | ||
| Recovered | 12 (15.4) | 6 (7.7) | ||
| Markedly effective | 18 (23.1) | 13 (16.6) | ||
| Effective | 37 (47.4) | 35 (44.9) | ||
| Ineffective | 11 (14.1) | 24 (30.8) | ||
| Efficiency | 67 (85.95) | 54 (69.2) |
- Citation: Yang T, Yu H, Han D, Xie Z. Combined mesenchymal and neural stem cell therapy enhances neurological recovery in cerebral infarction. World J Stem Cells 2025; 17(9): 110663
- URL: https://www.wjgnet.com/1948-0210/full/v17/i9/110663.htm
- DOI: https://dx.doi.org/10.4252/wjsc.v17.i9.110663